Hikma Pharmaceuticals

Dacarbazine

  1. Home
  2.  / 
  3. J Code
  4.  / Dacarbazine – J9130

Manufacturer:

Hikma Pharmaceuticals

Name:

Dacarbazine

HCPCS Code Descriptor:

Dacarbazine, 100 mg

Category:

J Code

HCPCS:

J9130

NDC(s):

63323-0128-20, 63323-0127-10, 00703-5075-01, 00703-5075-03, 00143-9245-10

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

Dacarbazine is an Oncology drug manufactured by Hikma Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9130 is aligned to the drug Dacarbazine.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/86

HCPCS Effective Date:

1/1/04

HCPCS Short Description:

Dacarbazine 100 mg inj

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found

Dacarbazine - J9130